FDA approves new treatment for hepatitis C
August 3, 2017 – The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with…
cirrhosis
Hepatorenal syndrome and large-volume paracentesis
Averting a Crisis. Takeaways Hepatorenal syndrome (HRS), impaired renal function resulting from advanced liver disease, is characterized by renal vasoconstriction,…
